Release Date: 22/06/09 16:58 Summary: Declaration of Force Majeure Price Sensitive: Yes Download Document 77.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%